Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar
Shots:
- Medicure is responsible for the regulatory approval process for the product
- The agreement grants an exclusive right to Medicure to market & sell the product in the US- Canada & the EU
- The product fits well with Medicure's mission of being a significant CV company focused on the US market
Ref: Medicure | Image: CNW Group
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
